News
Medtronic is one of the largest pure-play medical device stocks you can buy. The stock is yielding a historically attractive ...
1d
Stocktwits on MSNCMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says AnalystsAnalysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...
Medtronic (NYSE:MDT) experienced a price increase of 7% over the last quarter, which may have been influenced by notable ...
The healthcare industry is a behemoth, with annual expenditures totaling $4.9 trillion in the United States alone. It's a ...
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...
The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.
Goldman Sachs analyst David Roman reiterated a Sell rating on Medtronic today and set a price target of $78.00. The company’s shares closed today at $89.92. Take advantage of TipRanks Premium at 50% ...
4d
Stocktwits on MSNMedtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-OffHealth technology company Medtronic plc (MDT) on Tuesday announced the appointment of Chad Spooner as CFO of MiniMed. The ...
Medtronic PLC closed 7.97% below its 52-week high of $96.25, which the company achieved on March 10th.
Nearly 70 years into her history, Barbie is still undergoing regular makeovers. | Nearly 70 years into her history, Barbie is ...
Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...
Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results